JPS59115349A - Thermally sterilizable polyolefin composition and product - Google Patents
Thermally sterilizable polyolefin composition and productInfo
- Publication number
- JPS59115349A JPS59115349A JP58236511A JP23651183A JPS59115349A JP S59115349 A JPS59115349 A JP S59115349A JP 58236511 A JP58236511 A JP 58236511A JP 23651183 A JP23651183 A JP 23651183A JP S59115349 A JPS59115349 A JP S59115349A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- assembly
- bag
- film
- ethylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/32—Layered products comprising a layer of synthetic resin comprising polyolefins
- B32B27/322—Layered products comprising a layer of synthetic resin comprising polyolefins comprising halogenated polyolefins, e.g. PTFE
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/04—Homopolymers or copolymers of ethene
- C08L23/08—Copolymers of ethene
- C08L23/0807—Copolymers of ethene with unsaturated hydrocarbons only containing more than three carbon atoms
- C08L23/0815—Copolymers of ethene with aliphatic 1-olefins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2323/00—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers
- C08J2323/02—Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers not modified by chemical after treatment
- C08J2323/16—Ethene-propene or ethene-propene-diene copolymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/03—Polymer mixtures characterised by other features containing three or more polymers in a blend
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/04—Homopolymers or copolymers of ethene
- C08L23/06—Polyethene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/10—Homopolymers or copolymers of propene
- C08L23/14—Copolymers of propene
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Materials For Medical Uses (AREA)
- Laminated Bodies (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
非経口溶g(parentraL 5oLrbt、1
ons)は、流体取替え(ft1bicl repla
cement )、電解質取替え(electroly
te replacement ) を広範に含みそし
て医薬(drlLg medication )のだめ
のビヒクルである。溶液は、血漿、血小板、赤面球、腎
臓透析溶液、生理的食塩水溶液及び栄養製品を含む。こ
れらの溶液は、最初ガラスビンに入れられていだが、し
かしながら、数年前、コラプシプル(collapsi
ble )非経口用溶液バッグの導入によって、可撓性
のバッグは外部の空気がシステムに入ることなく空にな
るので空中汚染は相当減少された。DETAILED DESCRIPTION OF THE INVENTION Parenteral 5oLrbt, 1
ons) is a fluid replacement (ft1bicl repla
cement), electrolyte replacement
It contains a wide range of drugs (te replacement) and is a valuable vehicle for medicine (drlLg medication). Solutions include plasma, platelets, blush bulbs, kidney dialysis solutions, saline solutions and nutritional products. These solutions were initially packaged in glass bottles, however, several years ago, collapsiple
ble) With the introduction of parenteral solution bags, airborne contamination has been considerably reduced as the flexible bags are emptied without outside air entering the system.
非経口用溶液バッグの製造に使用される樹脂の一般的要
件は、可撓性、透明性、低温における強じん性、ヒート
シール性、良好な加工性、水分蒸気耐透過性、及び滅菌
できることを含む。工業はこの目的に対して高度に可塑
化されたpVCフィルムを現在使用している。この樹脂
は上記要件の大部分を満足するけれども、可塑剤を殆ん
ど含吐ないか又は全然含まない材料が好ましい。pVC
フィルムも又水蒸気透過性に対してそんなに抵抗性では
なく、結果として、非経口用浴液の水分の連続的損失は
その貯蔵寿命を相当減じる。それ故に、バッグは低い水
蒸気透過速度(WVTR)を有するように設計されたフ
ィルム樹脂から製造されたオーバーパウチ(over’
voフッ’、/ニア+、’+内に密封され得ることが
必較でおる。最近、オーバーパウチフィルムは高密度ポ
リエチレン及びブチルゴムのブレンドから製造され、そ
して約4−5ミルの厚さのフィルムに押出されて必要な
iP’ V T Rを与える。この厚さは通常物性にと
ってより必要とされそして組立体のコストを増す。オー
バーパウチ樹脂の他の欠点は、それが内側バッグの内容
物の容易力且つ正しい識別に必要とされる重要な特性で
ある所望の透明性に欠けているということである。General requirements for resins used in the manufacture of parenteral solution bags include flexibility, transparency, toughness at low temperatures, heat sealability, good processability, resistance to moisture vapor permeation, and ability to be sterilized. include. The industry currently uses highly plasticized pVC films for this purpose. Although the resin satisfies most of the above requirements, materials containing little or no plasticizer are preferred. pVC
Films are also not very resistant to water vapor permeability, and as a result, continuous loss of water in a parenteral bath solution considerably reduces its shelf life. Therefore, the bag is an over' pouch manufactured from a film resin designed to have a low water vapor transmission rate (WVTR).
It is essential that it can be sealed within the vofu', /near+,'+. Recently, overpouch films have been manufactured from blends of high density polyethylene and butyl rubber and extruded into films approximately 4-5 mils thick to provide the required iP'VTR. This thickness is usually more required for physical properties and adds to the cost of the assembly. Another drawback of overpouch resin is that it lacks the desired transparency, an important property needed for easy and correct identification of the contents of the inner bag.
故に本発明の目的は改良された透明性及び水蒸気耐透過
性の滅菌可能なオーバーパウチフィルムの製造に好適な
樹脂処決を提供することである。It is therefore an object of the present invention to provide a resin solution suitable for the production of sterilizable overpouch films of improved transparency and water vapor permeation resistance.
本発明の目的は非経口用溶液の直接及び間接の封じ込め
(containment )のだめの滅菌可能な(5
terilizable )、コラゾシブルハッグの製
造に有用なフィルムを提供することでもある。The object of the present invention is to provide a sterilizable (550ml) container for direct and indirect containment of parenteral solutions.
It is also an object of the present invention to provide a film useful in the production of collazable hugs.
本発明の他の目的は改良された押しつぶし可能な静脈内
用バッグ組立体を提供することである。Another object of the present invention is to provide an improved collapsible intravenous bag assembly.
他の目的は明細書及び特許請求の範囲を読めば容易にわ
かる。Other objectives will be readily apparent from reading the specification and claims.
本発明に従えば、
(a)エチレン約1重量%乃至約6重量夕g及びプロピ
レン約94重量%乃至約99重量%のランダム共重合体
約10重量%乃至60重量%、(b)エチレンと少なく
とも1種のC4−Cl1lα−オレフィンコモノマーと
の共重合により製造されそして約0.91511m /
cc乃至約0.940rm/ ccの密度を有する線
状侭密度ポリエチレン約40重量%乃至約90重量%の
ブレンドを含有して成る滅菌可能なフィルム樹脂組地物
が提供される。In accordance with the present invention, (a) about 10% to 60% by weight of a random copolymer of about 1% to about 6% by weight of ethylene and about 94% to about 99% by weight of propylene; prepared by copolymerization with at least one C4-Cl1lα-olefin comonomer and about 0.91511 m/
A sterilizable film resin composition is provided comprising a blend of about 40% to about 90% by weight linear side-density polyethylene having a density of cc to about 0.940 rm/cc.
ランダム共重合体成分は、好ましくi、t2ao℃にお
いて約i、oり710分乃至約5.0r710分の範囲
のメルトフローを有する。かかる重合体は商業的に容易
に入手可能であシ、従ってそれらの製造は討論する必要
はない。The random copolymer component preferably has a melt flow in the range of about 710 minutes at 2oC to about 710 minutes at 5.0oC. Such polymers are readily available commercially, so their manufacture is unnecessary.
以後成るときはL L i) P Eとして表わされる
線状低密度ポリエチレン成分はエチレン及び少なく、!
:41mのC4−Cl3α−オレフィンコモノマーのイ
ンターポリマーである。好ましくはα−オレフィンコモ
ノマーは分子当94−8個の炭素原子を含有する。特に
好適なコモノマーの例はブテン−1、ペンテン−1、ヘ
キセン−1,4−メチル−ペンテン−1、ヘプテン−1
、オクテン−1及びその混合物たとえばブテン−1/ヘ
キセン−1及びブテン−1/オクテン−1等である。こ
れらのLLDPE樹脂は、オートクレブ又は管状反応器
中の低圧乃至中圧又は高圧接触重合における蒸気、溶液
又はスラリー法を使用して最近導入された接触法(ca
talytic processes )の何れかによ
り製造することができる。樹脂は、好ましくは190℃
において約0.5′?/10分乃至約51/10分のメ
ルトインデックスを有する。種々の好適な樹脂が必要と
される密度及びメルトフロー範囲内で商業的に入手可能
でおる。The linear low-density polyethylene component, expressed as L L i) PE, is ethylene and less,!
:41m C4-Cl3α-olefin comonomer interpolymer. Preferably the alpha-olefin comonomer contains 94-8 carbon atoms per molecule. Examples of particularly suitable comonomers are butene-1, pentene-1, hexene-1,4-methyl-pentene-1, heptene-1
, octene-1 and mixtures thereof such as butene-1/hexene-1 and butene-1/octene-1. These LLDPE resins can be produced using the recently introduced catalytic method (ca.
talytic processes). The resin is preferably heated to 190°C.
About 0.5'? /10 minutes to about 51/10 minutes. A variety of suitable resins are commercially available within the required density and melt flow ranges.
樹脂ブレンドの1つの随意の成分は改良された透明性の
フィルムを製造するのに有効な量で加えられた剤である
。好適な剤の例は安息香酸ナトリウム、ソペンソリデン
ソルピトール、ソルビタンモノオレエイト他である。通
常、核剤は全重合体の重量を基準として、約0.1重量
%乃至約2重量%の量で加えられる。約2重量%乃至約
15重量%の高密度ポリエチレン、即ち、少なくとも0
、945 fm / ccの密度を有す−るエチレンの
単独1合体をヒートシール範囲を増加する目的で他の随
意の成分として前記樹脂中に含ませることもできる。こ
の特性は良好なシールをするための最小時間とフィルム
が標準ヒートシーリング装置を使用することにより端か
ら端まで燃焼する( burnthsowght )前
の最大時間との間の時間として定義される。One optional component of the resin blend is an agent added in an effective amount to produce a film of improved transparency. Examples of suitable agents are sodium benzoate, sopensolidensorpitol, sorbitan monooleate, and others. Typically, the nucleating agent is added in an amount of about 0.1% to about 2% by weight, based on the weight of the total polymer. from about 2% to about 15% by weight high density polyethylene, i.e. at least 0%
, 945 fm/cc can also be included as another optional component in the resin for the purpose of increasing heat seal range. This characteristic is defined as the time between the minimum time for a good seal and the maximum time before the film burns through using standard heat sealing equipment.
本発明のブレンド組成物は、高い透明性の他に、他の望
ましい性質、たとえば可撓性、低温での強じん性、ヒー
トシール性を示すブロー成形フィルム又はキャストフィ
ルム製品に容易に加工可能である。このフィルムは良好
な水蒸気耐透過性も有し、そしてその物性に不利に有意
に影響することな(1210Gでスチーム滅菌すること
ができる。In addition to high transparency, the blend compositions of the present invention can be readily processed into blown or cast film products that exhibit other desirable properties, such as flexibility, toughness at low temperatures, and heat sealability. be. The film also has good water vapor permeation resistance and can be steam sterilized at 1210 G without significantly affecting its physical properties.
最後に、該フィルムは直接又は間接接触において食品又
は医薬用途における使用を妨げる添加剤を含まない。Finally, the film does not contain additives that, in direct or indirect contact, would interfere with its use in food or pharmaceutical applications.
内側の非経口用溶液容器に使用されるとき、フィルムは
約3ミル乃至約10ミルの範囲の厚さを有するべきであ
り、これに対してオーバーパウチは約1ミル乃至約6ミ
ル厚より多くする必要はない。所望により、内側バッグ
又は外側バッグのために同時押出されたフィルムはフィ
ルム壁を通る水分又はガスの損失を減少させるのに使用
することができる。フルオロカーボン重合体、エチレン
−ビニルアルコール共重合体及びポリ塩化ビニリデン材
料の如き材料は好適な同時押出物の例である。When used in inner parenteral solution containers, the film should have a thickness in the range of about 3 mils to about 10 mils, whereas overpouches should have a thickness of about 1 mil to more than about 6 mils. do not have to. If desired, coextruded films for the inner bag or outer bag can be used to reduce moisture or gas loss through the film walls. Materials such as fluorocarbon polymers, ethylene-vinyl alcohol copolymers, and polyvinylidene chloride materials are examples of suitable coextrudates.
更に一層の改良は、非経口用溶液を含有する内側のシー
ルされたフィルムバッグ、少量の水を含有しそして内側
バッグを取囲む外側のシールされたフィルムバッグを具
備し、該外側バッグは内側バッグの対応する寸法より約
0.25インチ乃至約1.5インチ大きい巾及び長さを
有し、外側フィルム樹脂は、
((Z) エチレン約1重量%乃至約6重量%及びプ
ロピレン約94重量%乃至約99M量%のランダム共重
合体約lO重蓋夕に乃至60重量%、(b)エチレンと
少なくとも1種のC4−Cl3α−オレフィンコモノマ
ーとの共重合により製造されそして約0.9159m
/ cc乃至約0.940S’m/ ccの密度を有す
る線状低密度ポリエチレン約40重量%乃至約90重量
%のブレンドを含有して成る全非経口用溶液バッグ組立
体より得られる。A still further improvement comprises an inner sealed film bag containing the parenteral solution, an outer sealed film bag containing a small amount of water and surrounding the inner bag, the outer bag being larger than the inner bag. The outer film resin has a width and length of about 0.25 inches to about 1.5 inches greater than the corresponding dimensions of ((Z) about 1% to about 6% by weight ethylene and about 94% by weight propylene). (b) a random copolymer of from about 99 M weight percent to about 60 weight percent of a random copolymer, prepared by the copolymerization of ethylene and at least one C4-Cl3α-olefin comonomer and about 0.9159 M
A total parenteral solution bag assembly comprising a blend of about 40% to about 90% by weight linear low density polyethylene having a density of from about 0.940 S'm/cc to about 0.940 S'm/cc.
1つの態様においては、少量の水を、内側バッグを囲い
込むだめのシーリング操作が行なわれる前に外側パウチ
に直接加えられる。他の態様においては、少量の水は2
つのフィルム層から製造された別々のより小さい/4ウ
チ内に囲い込まれる。In one embodiment, a small amount of water is added directly to the outer pouch before the sealing operation of the reservoir enclosing the inner bag is performed. In other embodiments, the small amount of water is 2
Enclosed in separate smaller/four-walls made from two film layers.
経済的理由で、フィルムの1つは、外側バッグの樹脂と
同じ樹脂プ゛製造されるのが好適であるが、他の層は、
蒸気が逃げることを許容するが液体耐透過性である多孔
性材料から製造されるべきである。この目的に好適な材
料は商業的に入手可能な、たとえば、イー、アイ、デュ
ポン ドネモアス社から入手可能な Tyvek TM
橋かけ結合(spwn−bonded)ポリエチレンで
ある。それにより水分蒸気は外側バッグからよりはより
迅速に小さな・ぐウテから逃げることを許容され、かく
して内側バッグと外側バッグとの間の飽和した雰囲気(
5aturated atmosphere )を生じ
、水が内側バッグから逃げるための推進力を有効に除去
しそして水が蒸発しそして内側バッグを去る速度を減じ
る。より小さなパウチの1側の面積は対応する内側バッ
グ面積の約50%を越えるべきではない。For economic reasons, one of the films is preferably made of the same resin as that of the outer bag, while the other layers are
It should be manufactured from a porous material that allows vapor to escape but is resistant to liquid permeation. Materials suitable for this purpose are commercially available, such as Tyvek™ available from E.I., DuPont Donemore.
It is spwn-bonded polyethylene. Moisture vapor is thereby allowed to escape from the small container more quickly than from the outer bag, thus creating a saturated atmosphere between the inner and outer bags (
5 atmosphere), effectively removing the driving force for water to escape from the inner bag and reducing the rate at which water evaporates and leaves the inner bag. The area of one side of the smaller pouch should not exceed about 50% of the corresponding inner bag area.
内側バッグからの水蒸気の除去を抑制するために使用さ
れるべき実際の水の量は、非経口用溶液の満了日(ex
piration date)において内側分であるべ
きである。この量は明らかに場合により変わり、そして
非経口用溶液の最大許容貯蔵寿命、外側バッグの寸法及
び該バッグを通る水蒸気透過速度に依存するであろう。The actual amount of water that should be used to inhibit water vapor removal from the inner bag depends on the parenteral solution's expiration date (ex
piration date). This amount will obviously vary and will depend on the maximum allowable shelf life of the parenteral solution, the dimensions of the outer bag and the rate of water vapor transmission through the bag.
本発明の更なる特徴は小さなパウチ中の水以外の物質を
置換する能力である。たとえば、二酸化炭素吸収剤は小
さなパウチ内にシールするこトカできそして二酸化炭素
を内側バッグから除去することを助長し、又は酸素発生
器は内側バッグに酸素を加えることを助長するように加
えることができ、それKより拙小板貯蔵寿命は和尚増加
する。A further feature of the invention is the ability to displace substances other than water in small pouches. For example, a carbon dioxide absorbent can be sealed within a small pouch and help remove carbon dioxide from the inner bag, or an oxygen generator can be added to help add oxygen to the inner bag. It is possible to increase the shelf life of the small plate.
他の物質及びガスはシステムの貯蔵性能を改善するため
にこのようにして操作しそして制御することもできる。Other substances and gases can also be manipulated and controlled in this manner to improve the storage performance of the system.
内側バッグと外側バッグとの間の空間に挿入された小さ
なパウチの使用はすべてのパッヶーソング操作を大巾に
簡単化する。すべてのタイプの溶液に対して内側バッグ
を製造しそして目録を作るために1つのみのフィルム及
び厚さが必要であろう。更に、外側バッグはすべて、同
じ樹脂組成及び1つのフィルム厚さであることができる
。たとえばカラーコルディングにより識別できる異なっ
た小さなパウチのみを加んることか必要である。The use of a small pouch inserted into the space between the inner and outer bags greatly simplifies all packer song operations. Only one film and thickness would be needed to manufacture and inventory the inner bag for all types of solutions. Additionally, all outer bags can be of the same resin composition and one film thickness. It is necessary to include only different small pouches that can be distinguished, for example by color coding.
内側バッグに包装された材料が紫外線に感受性である場
什に、紫外線が/eツヶージされた製品に到達するのを
防止する少量の紫外線スクリーニング剤を外側バッグに
導入することができる。If the material packaged in the inner bag is sensitive to UV light, a small amount of UV screening agent can be introduced into the outer bag to prevent UV light from reaching the packaged product.
フィルム組成物は商エネルギー放射で滅菌することもで
きる。The film composition can also be sterilized with commercial energy radiation.
非経口用溶液バッグ組立体のバッグの何れが1つ又は両
方を他の重合体フィルム組成物から製造することができ
る。ただしそれらは熱又は照射により滅菌可能でありそ
して前記した可撓性、強じん性、ヒートシール性等の一
般的要件を満足するものとする。Either one or both of the bags of the parenteral solution bag assembly can be made from other polymeric film compositions. However, they must be sterilizable by heat or irradiation and satisfy the general requirements such as flexibility, toughness, heat sealability, etc. as described above.
下記実施例により本発明を更に説明する。The invention is further illustrated by the following examples.
実施例1
84、75部L L J) P E (エチレン及びブ
テン−1の共重合体、密度0.918 f /cc、メ
ルトインデックス1.Or/10分)、97.5%プロ
ピレン及び2.5%エチレンのランダム共重合体(密度
0.900r/Ce、 メルト70−2.05’/10
分)15部、ソベンヅリデンノルビトール0.25部を
含有する樹脂ブレンドを2.5ミル及び4゜5ミル厚さ
のプロー成形されたフィルムを製造するのに使用した。Example 1 84, 75 parts L L J) PE (copolymer of ethylene and butene-1, density 0.918 f/cc, melt index 1.Or/10 min), 97.5% propylene and 2. Random copolymer of 5% ethylene (density 0.900r/Ce, melt 70-2.05'/10
A resin blend containing 0.25 parts of sobenzulidene norbitol was used to make blown films of 2.5 mil and 4.5 mil thickness.
得られるフィルムは良好な透明性、強じん性を有し、容
易にヒートシール可能であり、そして可撓性であった。The resulting film had good transparency, toughness, was easily heat-sealable, and was flexible.
パウチはこれらのフィルムから製造され、水を満たされ
、ヒートシールされ、そして空気中に投げ上げられ(t
oss、ed)て1゜回のフットドロッジ(foot
drop )をシミュレートする。すべてのパウチは
周囲温度(6s′F″)で少なくとも6回のドロップに
生き残る。フィルムの水蒸気透過速度は約0.7S’/
ミル/100平方インチ/24時間であった。Pouches are made from these films, filled with water, heat sealed, and thrown up into the air (t
oss, ed) and 1° foot drudge (foot
drop). All pouches survive at least 6 drops at ambient temperature (6s'F"). The water vapor transmission rate of the film is approximately 0.7S'/
mils/100 square inches/24 hours.
5″×11“内側バッグから成る他の試験試料は4.5
ミルフイルムから調製した。これらは100Qccの水
を充填されそして2−5ミルフイルムの6 // ×1
2 //外側バッグ内に囲い込まれた。The other test specimen consisting of a 5" x 11" inner bag was 4.5
Prepared from Milfilm. These are filled with 100 Qcc of water and 6 // x 1 of 2-5 mil film
2 // Enclosed in the outer bag.
試料の一部は内側バッグと外側バッグとの間に70cc
の水を備えていた。試料のすべては1210Cで60分
間オートクレーブ中で行々われだスチーム滅菌試1験に
通った。A portion of the sample was separated by 70cc between the inner bag and the outer bag.
It was equipped with water. All of the samples passed one steam sterilization test performed in an autoclave at 1210C for 60 minutes.
LLDPIう゛/共重合体比を約85:15から約60
:40に変えたことを除いてすべての点で先の樹脂ブレ
ンドと同様な樹脂ブレンドから製造されたフィルムに関
する実験において等しく良好な結果が得られた。LLDPI/copolymer ratio from about 85:15 to about 60
Equivalently good results were obtained in experiments with films made from resin blends similar in all respects to the previous resin blends except that:
実施例2
実施例1に使用されたLLDPE及びプロピレン−エチ
レンランダム共重合体の他に種々の量の高密度ポリエチ
レン(0,952fm/cc )を含有する樹脂から5
ミルフイルムを製造した。コレラのフィルムの2つの層
のストリップを捧時間乃至1時間250°Fの空気オー
プン中に置いた。次いでストリップを取り出しそしてそ
れ自体に粘着する傾向について検査した。次いでこれら
の同じフンダストリーズ社(5entinel In
dustries )により製造されたインノ々ルスタ
イプシーラーをこれらの試験に対して使用した。加熱サ
イクルを変え(秒で)そして冷却時間(4秒)及び空気
圧(21psict)を一定に保った。良好なシールを
形成する最小時間及びフィルムが端から端まで燃焼する
前の最大時間を決定しそしてその時間差はシーリング範
囲であった。表1はこれらの実験からのデータを要約す
る。Example 2 5 from a resin containing varying amounts of high density polyethylene (0,952 fm/cc) in addition to the LLDPE and propylene-ethylene random copolymer used in Example 1.
Milfilm was manufactured. The two layered strips of cholera film were placed in open air at 250°F for one hour. The strips were then removed and examined for their tendency to stick to themselves. These same Fundindustries Inc. (5entinel In.
An Innolus type sealer manufactured by S.A. Industries, Ltd. was used for these tests. The heating cycle was varied (in seconds) and the cooling time (4 seconds) and air pressure (21 psic) were kept constant. The minimum time to form a good seal and the maximum time before the film burned from end to end were determined and the time difference was the sealing range. Table 1 summarizes the data from these experiments.
結果かられかる通り、少量の高密度ポリエチレンはヒー
トシール範囲を大巾に増加した。As can be seen from the results, a small amount of high density polyethylene greatly increased the heat seal range.
剥離試験は第3樹脂成分として高密度ポリエチレンを含
有する樹脂から製造されたフィルムにおいてシールが相
当強かったことも示した。他のフィルム特性はこの含有
によって不利には影響されなかった。Peel tests also showed that the seal was significantly stronger in films made from resins containing high density polyethylene as the third resin component. Other film properties were not adversely affected by this inclusion.
(1) DNSは粘着しなかった□僅かな粘着性本発明
の範囲から逸脱することなく本発明に対して多くの明細
書及び特許請求の範囲によって規定された変更及び修正
がなされ得ることは理解されるべきである。(1) DNS did not stick □ Slight stickiness It is understood that many changes and modifications may be made to the present invention without departing from the scope of the invention as defined by the specification and claims. It should be.
特許出願人 エル・パソ・ポリオレフインズ・■46
9882
@1983年8月18日@米国(US)■524114
0発 明 者 ジョン・エイチ・マイアースアメリカ合
衆国ペンシルベニア
リ・旧9081スウオースモア・スト
ラスヘブンアベニュー440Patent applicant El Paso Polyolefins ■46
9882 @ August 18, 1983 @ United States (US) ■ 524114 0 Inventor John H. Myers Pennsylvania, United States of America Formerly 9081 Swarthmore Strath Haven Avenue 440
Claims (1)
及びプロピレン約94重量%乃至約99重量%のランダ
ム共重合体約10重量%乃至60重量%、(b)エチレ
ンと少なくとも1種のC4−CIIIα−オレフィンコ
モノマーとの共重合により製造されそして約O1915
1m / cc乃至約0.940・ t m / cc
の密度を有する線状低密度ポリエチレン約40重量%乃
至約90重量%のブレンドを含有して成る滅菌可能なフ
ィルム樹脂組成物。 2 ランダムエチレンプロピレン共重合体が230°C
における約1.0f/10分乃至約5.0i710分の
範囲のメルトフローを有する特許請求の範囲第1項記載
の組成物。 3、線状低密度ポリエチレン成分のコモノマーが少なく
とも1種のC4−C,α−オレフィンである特許請求の
範囲第1項記載の組成物。 4、線状低密度ポリエチレンがエチレンとブテン−1の
共重合体である特許請求の範囲第1項記載の組成物。 5、線状低密度ポリエチレンが190℃における約o、
5r/lo分乃至約sr/lo分の範囲のメルトインデ
ックスを有する特許請求の範囲第1項記載の組成物。 6、改良された透明性を付与するための剤も含有する特
許請求の範囲第1項記載の組成物。 7、改良された透明性を付与するための剤が全重合体重
量を基準として約0.1重皿%乃至約2重量%の量のソ
ベンソリデンソルピトールである特許請求の範囲第6項
記載の組成物。 8、特許請求の範囲第1〜7項の何れかに記載の樹脂か
ら製造された滅菌可能なフィルム。 9、 フルオロカーがンmf合体、エチレン−ビニルア
ルコール共重合体及びポリ塩化ビニリデン樹脂から選ば
れた同時押出物樹脂と該樹脂の同時押出により製造され
た特許請求の範囲第8項記載のフィルム。 i o、 非経口用溶液を含有する内側のシールされ
たプラスチックフィルムバッグと、 該内側バッグを取囲むための外側のシールされたバッグ
を具備し、該外側バッグは内側バッグの対応する寸法よ
り約0.25インチ乃至約1.5インチ大きい巾及び長
さを有し、該外側フィルムバッグ樹月旨は、 (α)エチレン約1重量%乃至約6重量%及びプロピレ
ン約94重量%乃至約99重量%のランダム共重合体約
10重量%乃至60重量%、(b)エチレンと少なくと
も1種の64−Cl3α−オレフィンコモノマーとの共
重合により製造されそして約0.9151m / cc
乃至約0.940rm/ ccの密度を有する線状低密
度ポリエチレン約40重量%乃至約90重量%のブレン
ドを含有して成り、更に外側バッグと内側バッグとの間
の空間において、内側バッグフィルム壁を通しての非経
口用浴液からの成分の除去を制御し又は内側バッグフィ
ルム壁を通しての非経口用溶液への成分の添加を1b1
]御するのに十分な量の物質を具備する滅菌可能な非経
口用溶液バッグ組立体。 11、 ランダムエチレン−プロピレン共重合体が2
30°Gにおける約1.0f/10分乃至約5.09/
10分の範囲のメルトフローを有する特許請求の範囲第
10項記載の組立体。 17、線状低密度ポリエチレン成分のコモノマーが少な
くとも1種のC,−C,α−オレフィンである特許請求
の範囲第10項記載の組立体。 13 線状低密度ポリエチレンがエチレンとブテン−1
の共重合体である特許請求の範囲第10項記載の組立体
。 z、H状低密度ポリエチレンが190℃における約0.
5 ? / 10分乃至約5.Of、/10分の範囲の
メルトインデックスを有する特許請求の範囲第10項記
載の組立体。 15外41111フイルムバツグ樹脂ブレンドハElj
された透明性を付与するだめの剤も含有する特許請求の
範囲第10項記載の組立体。 16、改良された透明性を付与するための剤が全重合体
重量を基準として約0.1重量%乃至約2重量%の量の
ジペンソリデンソルビトールである特許請求の範囲第1
5項記載の組立体。 17、該物質が非経口用溶液からの蒸気形態の水の除去
を抑制するのに十分な量の水である特許請求の範囲第1
0項記載の組立体。 18 該非経口用溶液が血小板であり、そして該物質が
内側バッグフィルム壁を通して血小板に酸素を加えるの
に十分な量の酸素発生性化合物である特許請求の範囲第
10項記載の組立体。 19、該非経口用溶液が血小板であり、そして該物質が
内側バッグフィルム壁を通して血小板から二酸化炭素を
除去するのに十分な量の二酸化炭素吸収剤である特許請
求の範囲第10項記載の組立体。 20、該物質が内側バッグと外側バッグとの間の空間に
位置づけられたシールされたパウチ内に囲い込まれてお
り、そして該パウチの少なくとも1つの壁は蒸気及びガ
スを透過させることができるが、液体透過性に対しては
抵抗性である特許請求の範囲第10項記載の組立体。 21、少なくとも0.9459m / ccの密度を有
する高密度ポリエチレン単独重合体約2重量%乃至約1
5重量%も含有する特許請求の範囲第1項記載の組成物
。 22、、外側フィルムバッグ樹脂は少なくとも0、 (
1451m / ccの密度を有する高密度ポリエチレ
ン単独重合体約2重量%乃至約15重量%も含有する特
許請求の範囲第10項記載の組立体。[Claims] 1. (a) About 1% to about 6% by weight of ethylene
and about 10% to 60% by weight of a random copolymer of about 94% to about 99% propylene, (b) prepared by copolymerization of ethylene and at least one C4-CIII α-olefin comonomer and about O1915
1m/cc to approx. 0.940・tm/cc
A sterilizable film resin composition comprising a blend of from about 40% to about 90% by weight of linear low density polyethylene having a density of . 2 Random ethylene propylene copolymer at 230°C
The composition of claim 1 having a melt flow ranging from about 1.0 f/10 min to about 5.0 i710 min. 3. The composition according to claim 1, wherein the comonomer of the linear low density polyethylene component is at least one C4-C,α-olefin. 4. The composition according to claim 1, wherein the linear low density polyethylene is a copolymer of ethylene and butene-1. 5. Linear low density polyethylene has a temperature of about o at 190°C,
The composition of claim 1 having a melt index in the range of 5r/lo minutes to about sr/lo minutes. 6. The composition according to claim 1, which also contains an agent for imparting improved transparency. 7. Claim 6, wherein the agent for imparting improved transparency is sobensolidensorpitol in an amount of about 0.1% to about 2% by weight based on total polymer weight. Compositions as described in Section. 8. A sterilizable film produced from the resin according to any one of claims 1 to 7. 9. The film of claim 8 produced by coextrusion of said resin with a coextrudate resin selected from fluorocarne mf polymer, ethylene-vinyl alcohol copolymer, and polyvinylidene chloride resin. io, comprising an inner sealed plastic film bag containing a parenteral solution and an outer sealed bag for surrounding the inner bag, the outer bag being approximately smaller than the corresponding dimension of the inner bag; The outer film bag has a width and length of 0.25 inches to about 1.5 inches and contains (α) about 1% to about 6% by weight ethylene and about 94% to about 99% by weight propylene. (b) from about 10% to 60% by weight of a random copolymer prepared by copolymerization of ethylene and at least one 64-Clα-olefin comonomer and about 0.9151 m/cc;
the inner bag film wall in the space between the outer bag and the inner bag; 1b1 to control the removal of ingredients from the parenteral bath solution through or the addition of ingredients to the parenteral solution through the inner bag film wall.
] A sterilizable parenteral solution bag assembly containing a quantity of substance sufficient to control the parenteral solution. 11. Random ethylene-propylene copolymer is 2
Approximately 1.0 f/10 minutes to approximately 5.09/ at 30°G
11. An assembly according to claim 10 having a melt flow in the range of 10 minutes. 17. The assembly of claim 10, wherein the comonomer of the linear low density polyethylene component is at least one C,-C,α-olefin. 13 Linear low density polyethylene contains ethylene and butene-1
11. The assembly of claim 10, which is a copolymer of z, H-shaped low density polyethylene has a temperature of about 0.
5? / 10 minutes to about 5. 11. The assembly of claim 10 having a melt index in the range of /10 minutes. 15 outside 41111 film bag resin blend ha Elj
11. An assembly according to claim 10, which also contains a protective agent that imparts the desired transparency. 16. Claim 1, wherein the agent for imparting improved clarity is dipene soliden sorbitol in an amount of about 0.1% to about 2% by weight based on total polymer weight.
Assembly according to item 5. 17. Claim 1, wherein the substance is water in an amount sufficient to inhibit the removal of water in vapor form from the parenteral solution.
The assembly described in item 0. 18. The assembly of claim 10, wherein the parenteral solution is platelets and the substance is an oxygen-generating compound in an amount sufficient to oxygenate the platelets through the inner bag film wall. 19. The assembly of claim 10, wherein the parenteral solution is platelets and the substance is a carbon dioxide absorbent in an amount sufficient to remove carbon dioxide from the platelets through the inner bag film wall. . 20, the substance is enclosed within a sealed pouch located in a space between an inner bag and an outer bag, and at least one wall of the pouch is permeable to vapors and gases; 11. The assembly of claim 10, wherein the assembly is resistant to liquid permeability. 21. from about 2% to about 1% by weight of a high density polyethylene homopolymer having a density of at least 0.9459 m/cc
A composition according to claim 1 containing also 5% by weight. 22, the outer film bag resin has at least 0, (
11. The assembly of claim 10, also comprising from about 2% to about 15% by weight high density polyethylene homopolymer having a density of 1451 m/cc.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45094882A | 1982-12-20 | 1982-12-20 | |
US450948 | 1982-12-20 | ||
US524114 | 1983-08-18 | ||
US469882 | 1990-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS59115349A true JPS59115349A (en) | 1984-07-03 |
Family
ID=23790175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58236511A Pending JPS59115349A (en) | 1982-12-20 | 1983-12-16 | Thermally sterilizable polyolefin composition and product |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS59115349A (en) |
BE (1) | BE898469A (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59174639A (en) * | 1983-03-22 | 1984-10-03 | レクセン・プロダクツ・カンパニー | Impact strength-improved high transparency propylene polymercomposition |
JPS59202244A (en) * | 1983-05-02 | 1984-11-16 | Idemitsu Petrochem Co Ltd | Polyolefin resin composition |
JPS61255952A (en) * | 1985-05-09 | 1986-11-13 | Nippon Petrochem Co Ltd | Highly transparent polyolefin composition |
JPS6257555A (en) * | 1985-09-06 | 1987-03-13 | 昭和電工株式会社 | Medical bag |
JPS6264363A (en) * | 1985-09-17 | 1987-03-23 | 昭和電工株式会社 | Medical bag |
JPH08196620A (en) * | 1995-01-27 | 1996-08-06 | Terumo Corp | Extending catheter and its manufacture |
JP2017018626A (en) * | 2009-10-12 | 2017-01-26 | ニュー ヘルス サイエンシーズ、インク.New Health Sciences, Inc. | Blood storage bag system and depletion device having oxygen and carbon dioxide depletion ability |
US9968718B2 (en) | 2011-03-28 | 2018-05-15 | New Health Sciences, Inc. | Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly |
US10065134B2 (en) | 2010-05-05 | 2018-09-04 | New Health Sciences, Inc. | Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device |
US10136635B2 (en) | 2010-05-05 | 2018-11-27 | New Health Sciences, Inc. | Irradiation of red blood cells and anaerobic storage |
US10251387B2 (en) | 2010-08-25 | 2019-04-09 | New Health Sciences, Inc. | Method for enhancing red blood cell quality and survival during storage |
US10583192B2 (en) | 2016-05-27 | 2020-03-10 | New Health Sciences, Inc. | Anaerobic blood storage and pathogen inactivation method |
US10603417B2 (en) | 2009-10-12 | 2020-03-31 | Hemanext Inc. | System for extended storage of red blood cells and methods of use |
US10687526B2 (en) | 2013-02-28 | 2020-06-23 | Hemanext Inc. | Gas depletion and gas addition devices for blood treatment |
US10849824B2 (en) | 2015-04-23 | 2020-12-01 | Hemanext Inc. | Anaerobic blood storage containers |
US11013771B2 (en) | 2015-05-18 | 2021-05-25 | Hemanext Inc. | Methods for the storage of whole blood, and compositions thereof |
US11284616B2 (en) | 2010-05-05 | 2022-03-29 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
US11350626B2 (en) | 2015-03-10 | 2022-06-07 | Hemanext Inc. | Oxygen reduction disposable kits, devices and methods of use thereof (ORDKit) |
US12089589B2 (en) | 2009-10-12 | 2024-09-17 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58157839A (en) * | 1982-03-16 | 1983-09-20 | Nippon Oil Co Ltd | Impact-resistant polyolefin resin composition |
JPS58206647A (en) * | 1982-05-28 | 1983-12-01 | Mitsubishi Petrochem Co Ltd | Resin composition for extrusion molding |
JPS5941342A (en) * | 1982-09-01 | 1984-03-07 | Asahi Chem Ind Co Ltd | Molding resin composition |
JPS5945344A (en) * | 1982-09-07 | 1984-03-14 | Mitsubishi Petrochem Co Ltd | Preparation of resin film |
-
1983
- 1983-12-15 BE BE0/212054A patent/BE898469A/en not_active IP Right Cessation
- 1983-12-16 JP JP58236511A patent/JPS59115349A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58157839A (en) * | 1982-03-16 | 1983-09-20 | Nippon Oil Co Ltd | Impact-resistant polyolefin resin composition |
JPS58206647A (en) * | 1982-05-28 | 1983-12-01 | Mitsubishi Petrochem Co Ltd | Resin composition for extrusion molding |
JPS5941342A (en) * | 1982-09-01 | 1984-03-07 | Asahi Chem Ind Co Ltd | Molding resin composition |
JPS5945344A (en) * | 1982-09-07 | 1984-03-14 | Mitsubishi Petrochem Co Ltd | Preparation of resin film |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59174639A (en) * | 1983-03-22 | 1984-10-03 | レクセン・プロダクツ・カンパニー | Impact strength-improved high transparency propylene polymercomposition |
JPS59202244A (en) * | 1983-05-02 | 1984-11-16 | Idemitsu Petrochem Co Ltd | Polyolefin resin composition |
JPS61255952A (en) * | 1985-05-09 | 1986-11-13 | Nippon Petrochem Co Ltd | Highly transparent polyolefin composition |
JPS6257555A (en) * | 1985-09-06 | 1987-03-13 | 昭和電工株式会社 | Medical bag |
JPS6264363A (en) * | 1985-09-17 | 1987-03-23 | 昭和電工株式会社 | Medical bag |
JPH0411220B2 (en) * | 1985-09-17 | 1992-02-27 | ||
JPH08196620A (en) * | 1995-01-27 | 1996-08-06 | Terumo Corp | Extending catheter and its manufacture |
US10603417B2 (en) | 2009-10-12 | 2020-03-31 | Hemanext Inc. | System for extended storage of red blood cells and methods of use |
JP2017018626A (en) * | 2009-10-12 | 2017-01-26 | ニュー ヘルス サイエンシーズ、インク.New Health Sciences, Inc. | Blood storage bag system and depletion device having oxygen and carbon dioxide depletion ability |
US12089589B2 (en) | 2009-10-12 | 2024-09-17 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
US11433164B2 (en) | 2009-10-12 | 2022-09-06 | Hemanext Inc. | System for extended storage of red blood cells and methods of use |
US11284616B2 (en) | 2010-05-05 | 2022-03-29 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
US10065134B2 (en) | 2010-05-05 | 2018-09-04 | New Health Sciences, Inc. | Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device |
US10136635B2 (en) | 2010-05-05 | 2018-11-27 | New Health Sciences, Inc. | Irradiation of red blood cells and anaerobic storage |
US10251387B2 (en) | 2010-08-25 | 2019-04-09 | New Health Sciences, Inc. | Method for enhancing red blood cell quality and survival during storage |
US9968718B2 (en) | 2011-03-28 | 2018-05-15 | New Health Sciences, Inc. | Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly |
US10687526B2 (en) | 2013-02-28 | 2020-06-23 | Hemanext Inc. | Gas depletion and gas addition devices for blood treatment |
US11350626B2 (en) | 2015-03-10 | 2022-06-07 | Hemanext Inc. | Oxygen reduction disposable kits, devices and methods of use thereof (ORDKit) |
US11375709B2 (en) | 2015-03-10 | 2022-07-05 | Hemanext Inc. | Oxygen reduction disposable kits, devices and methods of use thereof |
US11638421B2 (en) | 2015-03-10 | 2023-05-02 | Hemanext Inc. | Oxygen reduction disposable kits, devices and methods of use thereof |
US10849824B2 (en) | 2015-04-23 | 2020-12-01 | Hemanext Inc. | Anaerobic blood storage containers |
US11013771B2 (en) | 2015-05-18 | 2021-05-25 | Hemanext Inc. | Methods for the storage of whole blood, and compositions thereof |
US11147876B2 (en) | 2016-05-27 | 2021-10-19 | Hemanext Inc. | Anaerobic blood storage and pathogen inactivation method |
US10583192B2 (en) | 2016-05-27 | 2020-03-10 | New Health Sciences, Inc. | Anaerobic blood storage and pathogen inactivation method |
US11911471B2 (en) | 2016-05-27 | 2024-02-27 | Hemanext Inc. | Anaerobic blood storage and pathogen inactivation method |
Also Published As
Publication number | Publication date |
---|---|
BE898469A (en) | 1984-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4540416A (en) | Heat-sterilizable polyolefin compositions and articles manufactured therefrom | |
JPS59115349A (en) | Thermally sterilizable polyolefin composition and product | |
US4536549A (en) | Heat-sterilizable polyolefin compositions and articles manufactured therefrom | |
US4528220A (en) | Plastic bags for medical solutions and blood | |
US4210686A (en) | Multi-layered plastic sheeting having high clarity, strength, and resistance to water vapor transmission | |
US5129894A (en) | Package units for medical purposes | |
US5993949A (en) | Multilayer, halide free, retortable barrier film | |
US4599276A (en) | Heat-sterilizable laminate films | |
US5998019A (en) | Multi-layered polymer structure for medical products | |
NO863809L (en) | HEAT STERILIZABLE PLASTIC MOVIES AND CONTAINERS MADE THEREOF. | |
GB2133018A (en) | Heat-sterilizable polyolefin compositions and articles manufactured therefrom | |
CA1284694C (en) | Polyolefin compositions | |
KR100650081B1 (en) | Multi-Layered Polymer Based Moisture Barrier Structure for Medical Grade Products | |
JPS59109542A (en) | Material for soft vessel | |
US4891253A (en) | Moisture barrier medical film | |
JP3890509B2 (en) | Storage container for blood components | |
JPH09262948A (en) | Resin laminate and its application | |
US4816342A (en) | Polymeric structure having improved barrier properties and method of making same | |
US4828892A (en) | Polyolefin film for steam sterilizable flexible containers | |
JP2002069213A (en) | Polyolefin resin film and laminated packaging material | |
CA1295449C (en) | Two layer polyolefin film for steam sterilizable flexible container | |
JPH10152596A (en) | Sealant film for retort | |
JP3625497B2 (en) | Medical container base material | |
JPH02227251A (en) | Transfusion bag | |
JPH06171040A (en) | Polyolefin-based base material for medical container |